Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Bladder: neoadjuvant immunotherapy & ctDNA

Petros Grivas, MD, PhD, University of Washington, Seattle, WA, discusses his research highlights from the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA. Dr Grivas specifically mentions data from the ABACUS trial (NCT02662309), the PURE-01 trial (NCT02736266) , the BLASST-01 trial (NCT03294304), as well as trials investigating enfortumab vedotin and erdafitinib.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.